Cite

HARVARD Citation

    Schett, G. et al. (2020). Anti-granulocyte-macrophage colony-stimulating factor antibody otilimab in patients with hand osteoarthritis: a phase 2a randomised trial. Lancet. pp. e623-e632. [Online]. 
  
Back to record